Escolar Documentos
Profissional Documentos
Cultura Documentos
According to a new market study published by Persistence Market Research (PMR), titled
Global Market Study on Home Infusion Therapy Devices: Needleless Connectors
to Witness Highest Growth by 2020, the market will reach a valuation of US$26,747.8
million by 2020 increasing from US$15,905.1 million in 2014. Expressed in CAGR, the market
will grow at 9% from 2014 to 2020.
Home infusion therapy is used for the treatment of diseases such as cancer, gastrointestinal
diseases, diabetes, dehydration, cystic fibrosis, and acute infections. The therapy is suitable
to administer drugs, nutrients, antibiotics, and other fluids into the veins to follow a schedule
as prescribed by the physician. As such, time spent by patients in hospitals, nursing homes,
or clinics is reduced considerably and helps in faster recovery due to the convenience and
comfort of home environment.
But, an increased adoption by patients of specialty infusion therapy opens prospects for the
home infusion therapy devices market. Also, increasing number of mergers and acquisitions,
growing use of ambulatory infusion pumps and product innovations are some of the trends
likely to come to fore in the market in coming years, as noted in the report.
In North America, the increasing patient pool with chronic diseases such as AIDS, cancer,
and diabetes is driving demand for home infusion therapy devices. Also, increasing geriatric
population is supporting growth of the market.
In Europe, the home infusion therapy devices market is expanding due to large geriatric
population base and growing popularity of procedures performed in non-hospital settings.
Furthermore, high prevalence of chronic diseases such as cancer, AIDS, and diabetes that
would need home infusion therapy are fueling demand for these devices.
As per statistics from National Center for Biotechnology Information (NCBI) - a subsidiary of
National Institute of Health, in 2012, about 3.4 million new cancer cases and 1.7 million
deaths due to cancer were recorded in Europe. Furthermore, as per data published by
European Diabetes Leadership Forum in 2012, almost 35 million adults suffer from diabetes
in 2011, which is estimated to increase to 43 million by 2030. This will collectively lead to
higher demand for home infusion therapy devices in the European region.
Request Sample Report: http://www.persistencemarketresearch.com/samples/2893
Market History:
Table of Content
Chapter 1 Preface 10
1.1 Report Description 10
1.2 Research Methodology 11
1.3 Assumptions 11
Chapter 2 Market Synopsis 12
Chapter 3 Porters Five Forces Analysis 14
3.1 Bargaining Power of Suppliers 14
3.2 Bargaining Power of Buyers 15
10
11
12
TABLE 18 Global syringe infusion pumps market, by region, 2010 2013 (US$ Mn) 37
TABLE 19 Global syringe infusion pumps market, by region, 2014 2020 (US$ Mn) 38
TABLE 20 Global insulin infusion pumps market, by region, 2010 2013 (US$ Mn) 39
TABLE 21 Global insulin infusion pumps market, by region, 2014 2020 (US$ Mn) 39
TABLE 22 Global enteral infusion pumps market, by region, 2010 2013 (US$ Mn) 40
TABLE 23 Global enteral infusion pumps market, by region, 2014 2020 (US$ Mn) 41
TABLE 24 Global ambulatory infusion pumps market, by region, 2010 2013 (US$ Mn) 41
TABLE 25 Global ambulatory infusion pumps market, by region, 2014 2020 (US$ Mn) 42
TABLE 26 Global PCA infusion pumps market, by region, 2010 2013 (US$ Mn) 43
TABLE 27 Global PCA infusion pumps market, by region, 2014 2020 (US$ Mn) 43
TABLE 28 Global implantable infusion pumps market, by region, 2010 2013 (US$ Mn) 44
TABLE 29 Global implantable infusion pumps market, by region, 2014 2020 (US$ Mn) 45
TABLE 30 Global home infusion therapy market, by application, 2010 2013 (US$ Mn) 46
TABLE 31 Global home infusion therapy market, by application, 2014 2020 (US$ Mn) 47
TABLE 32 Global anti-infectives market, by region, 2010 2013 (US$ Mn) 48
TABLE 33 Global anti-infectives market, by region, 2014 2020 (US$ Mn) 49
TABLE 34 Global enteral nutrition market, by region, 2010 2013 (US$ Mn) 49
13
14
TABLE 51 Global home infusion therapy market in cancer treatment, 2014 2020 (US$ Mn)
63
TABLE 52 Global home infusion therapy market, by region, 2010 2013 (US$ Mn) 65
TABLE 53 Global home infusion therapy market, by region, 2014 2020 (US$ Mn) 65
TABLE 54 North America home infusion therapy market, by country, 2010 2013 (US$ Mn)
67
TABLE 55 North America home infusion therapy market, by country, 2014 2020 (US$ Mn)
68
TABLE 56 Europe home infusion therapy market, by country, 2010 2013 (US$ Mn) 69
TABLE 57 Europe home infusion therapy market, by country, 2014 2020 (US$ Mn) 70
TABLE 58 Asia home infusion therapy market, by country, 2010 2013 (US$ Mn) 72
TABLE 59 Asia home infusion therapy market, by country, 2014 2020 (US$ Mn) 72
TABLE 60 Hospira, Inc.s Product and Service Categories 77
TABLE 61 B. Braun Melsungen AGs Product and Service Categories 79
TABLE 62 Caesarea Medical Electronics Product Categories 84
TABLE 63 Fresenius Kabi AGs Product Categories 85
TABLE 64 Smiths Medicals Product Categories 88
TABLE 65 CareFusion Corporations Product Categories 92
15
16
FIG. 14 B. Braun Melsungen AG Net Sales and Net Income 2011 2013 (US$ Mn) 82
FIG. 15 Fresenius Kabi AG Sales and Net Income 2011 2013 (US$ Mn) 86
FIG. 16 Smiths Group plc Revenue and Profit 2011 2013 (US$ Mn) 90
FIG. 17 CareFusion Corporation Revenue and Net Income 2011 2013 (US$ Mn) 93
FIG. 18 ICU Medical, Inc. Total Revenue and Net Income 2011 2013 (US$ Mn) 96
FIG. 19 JMS Co. Ltd. Net Sales and Net Income 2011 2013 (US$ Mn) 99
FIG. 20 Baxter Net Sales and Net Income 2011 2013 (US$ Mn) 102
FIG. 21 TERUMO CORPORATION Net Sales and Net Income 2011 2013 (US$ Mn) 104
About Us:
Persistence Market Research is a global market research firm specializing- syndicated research,
custom research, and consulting services
At Persistence Market Research (PMR), we are in the business of accelerating your business. As a fullservice market research firm, we stand committed to bringing more accuracy and speed to your business
decisions. From ready-to-purchase market research reports to customized global research solutions, our
engagement models are highly flexible without compromising on our deep-seated research values. Briefly
stated, our mission is to give you access to forecasts and trends analyses that put you on the path to
profitability.
Most enterprises believe that IT and databases are enough to make an accurate decision. While we do
not dispute that, consider this: How long does it take to make an accurate and strategic million-dollar
decision? We strive to deliver both even with demanding deadlines.
17
18